Font Size:
a
A
A
Keyword [HER-2 positive breast cancer]
Result: 1 - 20 | Page: 1 of 2
1.
Cai A Mixture Of Addition And Subtraction Treatment Of Her-2 Positive Breast Cancer, The Efficacy Of Clinical Research
2.
Black Rice Anthocyanins Inhibit HER-2-Positive Breast Cancer Epithelial–Mesenchymal Transition And Cell Metastasis Via FAK Signaling In Vitro
3.
Evaluation On Efficacy Of Trastuzumab In Her-2 Positive Breast Cancer Patients And Its Analysis Of Prognosis Influencing Factors
4.
Prognostic Analysis Of Targeted Therapy On T
1
Stage HER-2 Positive Breast Cancer
5.
Study Of Expression Of BRCA1,FANCF,CD44+CD24- In Triple Negative And Luminal B (Her-2 Positive) Breast Cancer
6.
The Role And Molecular Mechanism Of Autophahgy In Delphinidin-induced Anticancer Effects For HER-2 Positive Breast Cancer
7.
Experimental Study Of Brain-Targeted Compound Nano Micelles In The Treatment Of Brain Metastases From HER-2-positive Breast Cancer
8.
Analysis Of The Clinical And Pathological Features Of The HER-2 Positive Breast Cancer
9.
The Predictive Value Of Tils For Trastuzumab In Her-2 Positive Breast Cancer
10.
Comparison Of Efficacy Of THL And TCH Regimen In Neoadjuvant Treatment Of Her-2 Positive Breast Cancer
11.
RBM38 Induces Tarstuzumab Sensitivity In HER-2 Positive Breast Cancer By Increasing The Expression Of HER-2
12.
Advance In Molecular Targeted Therapy For HER-2 Positive Breast Cancer
13.
Cardiotoxic Analysis Of Trastuzumab Treatment In Her-2 Positive Breast Cancer Patients
14.
Molecular Mechanism Of Delphinidin Inducing Cell Cycle Arrest And Apoptosis In HER-2 Positive Breast Cancer Cells
15.
The Cardiotoxicity Risks Of Anthracycline And Trastuzumab In HER-2 Positive Breast Cancer Patients
16.
Application Of Magnetic Resonance Nanoparticles In HER-2 Positive Breast Cancer
17.
The Clinical Observation Of Trastuzumab In The Real World For The Treatment Of Her-2 Positive Breast Cancer
18.
Variation And Analysis Of Gene Copy Number In Her-2 Positive Breast Cancer
19.
Expression Of P95HER2 And Its Clinical Value In HER-2 Positive Breast Cancer Patients
20.
Clinical Study Of Neoadjuvant Chemotherapy With Trastuzumab For Breast Cancer With POSITIVE HER-2
<<First
<Prev
Next>
Last>>
Jump to